Implantation of Venous Access Port via Axillary Vein in the Operation of Breast Cancer: A Retrospective Study of 40 Cases_West China Medical Journal

Authors：

 MaoLing , LiuFangfang ,  HuangXuandong

Department of Thyroid and Breast Surgery, Huai’an Second People’s Hospital, Huai’an, Jiangsu 223001, P. R. China;

Corresponding author：

HuangXuandong, Email: xdhuang3970808@sina.com

Keywords：

Breast cancer; Axillary vein; Venous access port; Complications

DOI：

10.7507/1002-0179.201600183

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To summarize the advantages and complications of implantation of venous access port via axillary vein in the operation of breast cancer, and to explore the countermeasures against the complications. Methods A total of 40 female patients with breast cancer were enrolled in this observational study between January 2011 and September 2014. They were aged from 32 to 62 years with a mean of 49.3 years. The time for implantation, catheter life, reasons for port removal and complications were evaluated. Results The average time for implantation was 23.3 minutes. The catheter life ranged from 142 to 917 days with a mean of 395 days. Four patients (10%) had port-related complications including 2 cases of pocket infection and 2 of catheter dysfunction. Thirty-one ports were removed for termination of chemotherapy, and four were removed for complications. Conclusions It is simple and time-saving to implant venous access port via axillary vein in the operation of breast cancer. The incidence of pocket infection is high, and is expected to be reduced by choosing appropriate cases and taking strict aseptic norms.

Citation： MaoLing, LiuFangfang, HuangXuandong. Implantation of Venous Access Port via Axillary Vein in the Operation of Breast Cancer: A Retrospective Study of 40 Cases. West China Medical Journal, 2016, 31(4): 667-670. doi: 10.7507/1002-0179.201600183 Copy

1.	中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2013版)[J]. 中国癌症杂志, 2013, 23(8): 637-684.
2.	陈伟芬, 朱华, 赵秀英, 等. 乳腺癌患者化疗期间不同静脉输液途径的选择与血管保护的关系[J]. 护士进修杂志, 2006, 21(2): 105-107.
3.	Zaghal A, Khalife M, Mukherji D, et al. Update on totally implantable venous access devices[J]. Surg Oncol, 2012, 21(3): 207-215.
4.	Niederhuber JE, Von Moll LK, Niederhuber JE, et al. Experience with subcutaneous infusion ports in three hundred patients[J]. Surg Gynecol Obstet, 1988, 166(4): 295-301.
5.	Kurul S, Saip P, Aydin T, et al. Totally implantable venous-access ports: localproblems and extravasation injury[J]. Lancet Oncol, 2002, 3(11): 684-692.
6.	陈丽莉, 何惠燕, 毛晓群. 乳腺癌患者应用植入式中心静脉输液港的常见问题与对策[J]. 中华护理杂志, 2011, 46(11): 1116-1117.
7.	茅玲, 孙爱军, 黄选东, 等. 乳腺癌术中放置输液港的临床体会[J].中国美容医学, 2012, 21(10): 166-167.
8.	Niederhuber JE, Ensminger W, Gyves JW, et al. Totally implantable venous and arterial access system to replace external catheters in cancer treatment[J]. Surgery, 1982, 92(4): 706-712.
9.	莫美珍, 林称喜, 钟华英, 等. 乳腺癌患者应用植入式静脉输液港与PICC的效果比较[J]. 中国实用护理杂志, 2013, 29(24): 19-20.
10.	孙玉巧, 周涛, 李云涛, 等. 完全植入式静脉输液港的临床应用[J].中华外科杂志, 2014, 52(8): 608-611.
11.	Fazeny-Dorner B, Wenzel C, Berzlanovich A, et al. Central venous catheter pinch-off and fracture: recognition, prevention and management[J]. Bone Marrow Transplant, 2003, 31(10): 927-930.
12.	覃谦, 陈丽菊, 文燕舞, 等. TIAP与PICC在肿瘤患者化疗和营养支持治疗中的并发症比较和临床意义[J]. 中华普通外科杂志, 2012, 27(10): 843-844.
13.	Jan HC, Chou SJ, Chen TH, et al. Management and prevention of complications of subcutaneous intravenous infusion port[J]. Surg Oncol, 2012, 21(1): 7-13.
14.	邓宏武, 周征宇, 梁英, 等. PICC与CVPAS两种深静脉置管术在乳腺癌患者中的应用比较[J]. 武警医学, 2012, 23(10): 897-898.
15.	DiSipio T, Rye S, Newman B, et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis[J]. Lancet Oncol, 2013, 14(6): 500-515.
16.	Armer JM, Stewart BR. Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months[J]. Lymphology, 2010, 43(3): 118-127.

1. 中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2013版)[J]. 中国癌症杂志, 2013, 23(8): 637-684.
2. 陈伟芬, 朱华, 赵秀英, 等. 乳腺癌患者化疗期间不同静脉输液途径的选择与血管保护的关系[J]. 护士进修杂志, 2006, 21(2): 105-107.
3. Zaghal A, Khalife M, Mukherji D, et al. Update on totally implantable venous access devices[J]. Surg Oncol, 2012, 21(3): 207-215.
4. Niederhuber JE, Von Moll LK, Niederhuber JE, et al. Experience with subcutaneous infusion ports in three hundred patients[J]. Surg Gynecol Obstet, 1988, 166(4): 295-301.
5. Kurul S, Saip P, Aydin T, et al. Totally implantable venous-access ports: localproblems and extravasation injury[J]. Lancet Oncol, 2002, 3(11): 684-692.
6. 陈丽莉, 何惠燕, 毛晓群. 乳腺癌患者应用植入式中心静脉输液港的常见问题与对策[J]. 中华护理杂志, 2011, 46(11): 1116-1117.
7. 茅玲, 孙爱军, 黄选东, 等. 乳腺癌术中放置输液港的临床体会[J].中国美容医学, 2012, 21(10): 166-167.
8. Niederhuber JE, Ensminger W, Gyves JW, et al. Totally implantable venous and arterial access system to replace external catheters in cancer treatment[J]. Surgery, 1982, 92(4): 706-712.
9. 莫美珍, 林称喜, 钟华英, 等. 乳腺癌患者应用植入式静脉输液港与PICC的效果比较[J]. 中国实用护理杂志, 2013, 29(24): 19-20.
10. 孙玉巧, 周涛, 李云涛, 等. 完全植入式静脉输液港的临床应用[J].中华外科杂志, 2014, 52(8): 608-611.
11. Fazeny-Dorner B, Wenzel C, Berzlanovich A, et al. Central venous catheter pinch-off and fracture: recognition, prevention and management[J]. Bone Marrow Transplant, 2003, 31(10): 927-930.
12. 覃谦, 陈丽菊, 文燕舞, 等. TIAP与PICC在肿瘤患者化疗和营养支持治疗中的并发症比较和临床意义[J]. 中华普通外科杂志, 2012, 27(10): 843-844.
13. Jan HC, Chou SJ, Chen TH, et al. Management and prevention of complications of subcutaneous intravenous infusion port[J]. Surg Oncol, 2012, 21(1): 7-13.
14. 邓宏武, 周征宇, 梁英, 等. PICC与CVPAS两种深静脉置管术在乳腺癌患者中的应用比较[J]. 武警医学, 2012, 23(10): 897-898.
15. DiSipio T, Rye S, Newman B, et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis[J]. Lancet Oncol, 2013, 14(6): 500-515.
16. Armer JM, Stewart BR. Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months[J]. Lymphology, 2010, 43(3): 118-127.

West China Medical Journal

Implantation of Venous Access Port via Axillary Vein in the Operation of Breast Cancer: A Retrospective Study of 40 Cases

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content